Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – Biopharma External News
Nearly 2.9 million people have MS. A drug candidate targeting nerve coating gets FDA trial clearance. - Stock Titan
Google News – Pharmaceuticals External News
Crinetics Pharmaceuticals, Inc. SEC Filing (Sep 11, 2026) - Stock Titan
Google News – Biopharma External News
Experts call for stronger industry-academia partnerships to make India a global biopharma hub - The Hindu
Google News – Pharmaceuticals External News
Fine Foods & Pharmaceuticals N T M S p A : Half-year Financial Report as of 30 June 2026 - marketscreener.com
Google News – Biopharma External News
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials - manilatimes.net
Google News – Pharmaceuticals External News
Shuttle Pharmaceuticals Holdings, Inc. has Changed its Name to United Compute Inc - marketscreener.com
Google News – Pharmaceuticals External News
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared. - The Motley Fool
Google News – Pharmaceuticals External News
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus - Investing.com
Google News – Biopharma External News
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026 - marketscreener.com
Google News – Biopharma External News
mRNA cancer vaccines’ biggest barriers to market - BioPharma Dive
Google News – Pharmaceuticals External News
Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher - FXEmpire
Google News – Pharmaceuticals External News
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome - PR Newswire
Google News – Pharmaceuticals External News
Two patients start a trial for a genetic kidney disease with no FDA-approved therapy for its cause - Stock Titan
Google News – Pharmaceuticals External News

